Risk factors and clinical outcomes of gastric cancer identified by screening endoscopy: A case-control study

Journal of Gastroenterology and Hepatology (Australia)

Volumn 29, Issue 2, 2014, Pages 301-309

  Gong, Eun Jeong ^a   Ahn, Ji Yong ^a   Jung, Hwoon Yong ^a   Lim, Hyun ^a   Choi, Kwi Sook ^a   Lee, Jeong Hoon ^a   Kim, Do Hoon ^a   Choi, Kee Don ^a   Song, Ho June ^a   Lee, Gin Hyug ^a   Kim, Jin Ho ^a   Choi, Son Yeong ^a   Choe, Jae Won ^a   Kim, Min Ju ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Cancer screening; Endoscopy; Risk factors; Stomach neoplasms

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER SCREENING; CANCER SURVIVAL; CONTROLLED STUDY; ENDOSCOPY; FAMILY HISTORY; FEMALE; FOLLOW UP; GENDER; HELICOBACTER PYLORI; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; RISK FACTOR; SEX RATIO; STOMACH CANCER; SURVIVAL RATE; CASE CONTROL STUDY; DRINKING; GASTROSCOPY; HELICOBACTER INFECTION; MASS SCREENING; MIDDLE AGED; SEX DIFFERENCE; STOMACH TUMOR;

CANCER SCREENING; ENDOSCOPY; RISK FACTORS; STOMACH NEOPLASMS;

AGE FACTORS; AGED; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CASE-CONTROL STUDIES; CHOLESTEROL, LDL; DRINKING; FEMALE; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; RISK FACTORS; SEX FACTORS; STOMACH NEOPLASMS;

EID: 84903935081     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12387     Document Type: Article

References (39)

1. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J. Gastroenterol. 2006; 12: 354-362.
2. Jung KW, Park S, Won YJ etal. Prediction of cancer incidence and mortality in Korea, 2012. Cancer Res. Treat. 2012; 44: 25-31.
3. Everett SM, Axon AT. Early gastric cancer in Europe. Gut 1997; 41: 142-150.
4. Kong SH, Park DJ, Lee HJ etal. Clinicopathologic features of asymptomatic gastric adenocarcinoma patients in Korea. Jpn J. Clin. Oncol. 2004; 34: 1-7.
5. Whiting JL, Sigurdsson A, Rowlands DC, Hallissey MT, Fielding JW. The long term results of endoscopic surveillance of premalignant gastric lesions. Gut 2002; 50: 378-381.
6. Kampschoer GH, Fujii A, Masuda Y. Gastric cancer detected by mass survey. Comparison between mass survey and outpatient detection. Scand. J. Gastroenterol. 1989; 24: 813-817.
7. Hosokawa O, Miyanaga T, Kaizaki Y etal. Decreased death from gastric cancer by endoscopic screening: association with a population-based cancer registry. Scand. J. Gastroenterol. 2008; 43: 1112-1115.
8. Choi KS, Jun JK, Lee HY etal. Performance of gastric cancer screening by endoscopy testing through the National Cancer Screening Program of Korea. Cancer Sci. 2011; 102: 1559-1564.
9. Dan YY, So JB, Yeoh KG. Endoscopic screening for gastric cancer. Clin. Gastroenterol. Hepatol. 2006; 4: 709-716.
10. Tashiro A, Sano M, Kinameri K, Fujita K, Takeuchi Y. Comparing mass screening techniques for gastric cancer in Japan. World J. Gastroenterol. 2006; 12: 4873-4874.
11. Choi IJ. Gastric cancer screening and diagnosis. Korean J. Gastroenterol. 2009; 54: 67-76.
12. Leung WK, Wu MS, Kakugawa Y etal. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008; 9: 279-287.
13. Japanese Gastric Cancer A. Japanese classification of gastric carcinoma-2nd English Edition. Gastric Cancer 1998; 1: 10-24.
14. Gotoda T, Yanagisawa A, Sasako M etal. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer 2000; 3: 219-225.
15. Shimada Y, JGCA (The Japan Gastric Cancer Association). Gastric cancer treatment guidelines. Jpn J. Clin. Oncol. 2004; 34: 58.
16. Ahn JY, Jung HY, Choi KD etal. Endoscopic and oncologic outcomes after endoscopic resection for early gastric cancer: 1370 cases of absolute and extended indications. Gastrointest. Endosc. 2011; 74: 485-493.
17. Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann. Surg. Oncol. 2010; 17: 3077-3079.
18. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol. Microbiol. Scand. 1965; 64: 31-49.
19. Sano T, Okuyama Y, Kobori O, Shimizu T, Morioka Y. Early gastric cancer. Endoscopic diagnosis of depth of invasion. Dig. Dis. Sci. 1990; 35: 1340-1344.
20. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award lecture on cancer epidemiology and prevention. Cancer Res. 1992; 52: 6735-6740.
21. Uemura N, Okamoto S, Yamamoto S etal. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 2001; 345: 784-789.
22. D'Elia L, Rossi G, Ippolito R, Cappuccio FP, Strazzullo P. Habitual salt intake and risk of gastric cancer: a meta-analysis of prospective studies. Clin. Nutr. 2012; 31: 489-498.
23. Palli D, Galli M, Caporaso NE etal. Family history and risk of stomach cancer in Italy. Cancer Epidemiol. Biomarkers Prev. 1994; 3: 15-18.
24. Tramacere I, Negri E, Pelucchi C etal. A meta-analysis on alcohol drinking and gastric cancer risk. Ann. Oncol. 2012; 23: 28-36.
25. Wang WH, Huang JQ, Zheng GF, Lam SK, Karlberg J, Wong BC. Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis. J. Natl Cancer Inst. 2003; 95: 1784-1791.
26. Fiorenza AM, Branchi A, Sommariva D. Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects. Int. J. Clin. Lab. Res. 2000; 30: 141-145.
27. Alsheikh-Ali AA, Trikalinos TA, Kent DM, Karas RH. Statins, low-density lipoprotein cholesterol, and risk of cancer. J. Am. Coll. Cardiol. 2008; 52: 1141-1147.
28. Jafri H, Alsheikh-Ali AA, Karas RH. Baseline and on-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy. J. Am. Coll. Cardiol. 2010; 55: 2846-2854.
29. Tornberg SA, Carstensen JM, Holm LE. Risk of stomach cancer in association with serum cholesterol and beta-lipoprotein. Acta Oncol. 1988; 27: 39-42.
30. Guo E, Chen L, Xie Q, Chen J, Tang Z, Wu Y. Serum HDL-C as a potential biomarker for nodal stages in gastric cancer. Ann. Surg. Oncol. 2007; 14: 2528-2534.
31. Kitayama J, Hatano K, Kaisaki S, Suzuki H, Fujii S, Nagawa H. Hyperlipidaemia is positively correlated with lymph node metastasis in men with early gastric cancer. Br. J. Surg. 2004; 91: 191-198.
32. Palli D, Russo A, Saieva C, Salvini S, Amorosi A, Decarli A. Dietary and familial determinants of 10-year survival among patients with gastric carcinoma. Cancer 2000; 89: 1205-1213.
33. Han MA, Oh MG, Choi IJ etal. Association of family history with cancer recurrence and survival in patients with gastric cancer. J. Clin. Oncol. 2012; 30: 701-708.
34. Yatsuya H, Toyoshima H, Mizoue T etal. Family history and the risk of stomach cancer death in Japan: differences by age and gender. Int. J. Cancer 2002; 97: 688-694.
35. Kato I, Tominaga S, Matsumoto K. A prospective study of stomach cancer among a rural Japanese population: a 6-year survey. Jpn J. Cancer Res. 1992; 83: 568-575.
36. Lee WJ, Hong RL, Lai IR, Chen CN, Lee PH, Huang MT. Clinicopathologic characteristics and prognoses of gastric cancer in patients with a positive familial history of cancer. J. Clin. Gastroenterol. 2003; 36: 30-33.
37. Kunisaki C, Ishino J, Nakajima S etal. Outcomes of mass screening for gastric carcinoma. Ann. Surg. Oncol. 2006; 13: 221-228.
38. Mori Y, Arita T, Shimoda K, Yasuda K, Yoshida T, Kitano S. Effect of periodic endoscopy for gastric cancer on early detection and improvement of survival. Gastric Cancer 2001; 4: 132-136.
39. Miyamoto A, Kuriyama S, Nishino Y etal. Lower risk of death from gastric cancer among participants of gastric cancer screening in Japan: a population-based cohort study. Prev. Med. 2007; 44: 12-19.